<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/772A1E12-7175-46C0-B665-CE27930D15A8"><gtr:id>772A1E12-7175-46C0-B665-CE27930D15A8</gtr:id><gtr:name>Liverpool John Moores University</gtr:name><gtr:address><gtr:line1>Egerton Court</gtr:line1><gtr:line2>No 2 Rodney Street</gtr:line2><gtr:line4>Liverpool</gtr:line4><gtr:postCode>L3 5UX</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/A0A585E0-6B0D-4643-A3A6-47943B4CBFEF"><gtr:id>A0A585E0-6B0D-4643-A3A6-47943B4CBFEF</gtr:id><gtr:name>University of Liverpool</gtr:name><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line2>Abercromby Square</gtr:line2><gtr:line4>Liverpool</gtr:line4><gtr:postCode>L69 3BX</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/90DD3932-9EC0-40BC-AA51-0779C33D1F73"><gtr:id>90DD3932-9EC0-40BC-AA51-0779C33D1F73</gtr:id><gtr:name>MI Engineering Ltd</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/FC34E869-23CE-450A-BEE8-D01391E81064"><gtr:id>FC34E869-23CE-450A-BEE8-D01391E81064</gtr:id><gtr:name>IntelliHep Ltd</gtr:name><gtr:address><gtr:line1>Biosciences Incubator</gtr:line1><gtr:line2>Crown Street</gtr:line2><gtr:postCode>L69 7ZB</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/FC59975E-26E8-4A62-ABD8-A570DC6ABF06"><gtr:id>FC59975E-26E8-4A62-ABD8-A570DC6ABF06</gtr:id><gtr:name>Keele University</gtr:name><gtr:department>Inst for Science and Tech in Medicine</gtr:department><gtr:address><gtr:line1>Keele</gtr:line1><gtr:line4>Newcastle</gtr:line4><gtr:line5>Staffordshire</gtr:line5><gtr:postCode>ST5 5BG</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/FC59975E-26E8-4A62-ABD8-A570DC6ABF06"><gtr:id>FC59975E-26E8-4A62-ABD8-A570DC6ABF06</gtr:id><gtr:name>Keele University</gtr:name><gtr:address><gtr:line1>Keele</gtr:line1><gtr:line4>Newcastle</gtr:line4><gtr:line5>Staffordshire</gtr:line5><gtr:postCode>ST5 5BG</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/798CB33D-C79E-4578-83F2-72606407192C"><gtr:id>798CB33D-C79E-4578-83F2-72606407192C</gtr:id><gtr:name>EPSRC</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:line4>Swindon</gtr:line4><gtr:line5>Wiltshire</gtr:line5><gtr:postCode>SN2 1ET</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>CO_FUNDER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/772A1E12-7175-46C0-B665-CE27930D15A8"><gtr:id>772A1E12-7175-46C0-B665-CE27930D15A8</gtr:id><gtr:name>Liverpool John Moores University</gtr:name><gtr:address><gtr:line1>Egerton Court</gtr:line1><gtr:line2>No 2 Rodney Street</gtr:line2><gtr:line4>Liverpool</gtr:line4><gtr:postCode>L3 5UX</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A0A585E0-6B0D-4643-A3A6-47943B4CBFEF"><gtr:id>A0A585E0-6B0D-4643-A3A6-47943B4CBFEF</gtr:id><gtr:name>University of Liverpool</gtr:name><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line2>Abercromby Square</gtr:line2><gtr:line4>Liverpool</gtr:line4><gtr:postCode>L69 3BX</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/90DD3932-9EC0-40BC-AA51-0779C33D1F73"><gtr:id>90DD3932-9EC0-40BC-AA51-0779C33D1F73</gtr:id><gtr:name>MI Engineering Ltd</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/FC34E869-23CE-450A-BEE8-D01391E81064"><gtr:id>FC34E869-23CE-450A-BEE8-D01391E81064</gtr:id><gtr:name>IntelliHep Ltd</gtr:name><gtr:address><gtr:line1>Biosciences Incubator</gtr:line1><gtr:line2>Crown Street</gtr:line2><gtr:postCode>L69 7ZB</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3C738E77-AD80-4FA5-9FCB-02C2E548191D"><gtr:id>3C738E77-AD80-4FA5-9FCB-02C2E548191D</gtr:id><gtr:name>M I Engineering Ltd</gtr:name><gtr:address><gtr:line1>M I Engineering Ltd</gtr:line1><gtr:line2>Bromlet Street</gtr:line2><gtr:line3>Lye</gtr:line3><gtr:postCode>DY9 8HU</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/8C107475-670B-4B8A-A725-6FA0A2874084"><gtr:id>8C107475-670B-4B8A-A725-6FA0A2874084</gtr:id><gtr:firstName>Mark</gtr:firstName><gtr:otherNames>Andrew</gtr:otherNames><gtr:surname>Skidmore</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=BB%2FL023717%2F1"><gtr:id>A5B77A7D-5CD4-493B-A474-5A51FD1F6CEC</gtr:id><gtr:title>Advanced glycosaminoglycan sequencing</gtr:title><gtr:status>Active</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>BB/L023717/1</gtr:grantReference><gtr:abstractText>The interaction between proteins and cell-surface ligands underpin many biological processes such as cell growth, homeostasis, apoptosis and the ability of pathogens to invade host cells. One important family of cell surface ligands are the carbohydrate family of glycosaminoglycans (GAGs) found on the surface of almost all mammalian cells. Analysis of the sequence of the linear block-like arrangement of these GAGs is a significant technical challenge due to only miniscule quantities of pure material being (readily) available, poor chemistries and insensitive detection equipment. 

This research aims to develop and test a new method for sequencing these GAG polysaccharides utilising recent fundamental improvements made by the applicant. These developments include the exploitation of the opposite end of the molecule than is conventionally used (non-reducing end), with a vastly improved labelling mechanism and an advanced detection system for the conventional end of the molecule (reducing end). This approach will provide a powerful and sensitive sequencing technique capable of employing both ends of the GAG saccharide for characterization. 

The information gained from GAG sequencing will enable researchers to study previously elusive structures and processes that are biologically and medically significant.</gtr:abstractText><gtr:technicalSummary>The sequence determination of the biologically important glycosaminoglycan (GAG) polysaccharides remains a significant technical challenge for several reasons. These include a difficulty in obtaining sufficient quanitties of purified GAGs from biological samples, problematic labelling chemistries, insensitive instrumentation and the reliance on rare, and thus expensive, exoglycosidase enzymes to elucidate sequence identity.

This project will develop, evaluate and validate a novel approach in which two fundamental and radical improvements are incorporated. These are to combine a recently developed approach for efficient tethering of GAG saccharides via their non-reducing ends together with a vastly improved fluorescent label (BODIPY) and state-of-the-art detection system (LIF), developed in collaboration with an Industrial partner (MI Engineering Ltd.). This permits a novel &amp;quot;dual-end&amp;quot; sequencing method to be developed, permitting access to sequence information from both ends of the molecule, and providing two complementary opportunities to obtain sequence information.

This improved sequencing strategy with vastly improved detection (at least 20,000 fold, accessing zeptomole levels for the first time) will provide a powerful sequencing tool for the high throughput analysis of biologically and medically important GAGs, and open up new opportunities to exploit GAGs in biomedical applications.</gtr:technicalSummary><gtr:potentialImpactText>The biologically and medically family of carbohydrates, the glycosaminoglycans (GAGs), are present on the cell surface of almost all mammalian cells and are implicated in many crucial biological mechanisms such as cell growth, division, homeostasis and pathogen invasion. However, analysis of their sequence is a significant technical challenge compounded by the difficulty in obtaining sufficient purified material from biological samples. Sequencing techniques to date rely on relatively large amounts of starting material and are generally difficult, labour intensive, time consuming and relatively insensitive. 

The successful development of a rapid, sensitive and high throughput sequencing strategy will permit rapid progress to be made on investigations into the structure:function relationships of GAG saccharides and will ultimately contribute significantly to our understanding of GAG polysaccharides as major components of the glycome. This is a crucial facet of post-genome science, and will open up major new exploitation.</gtr:potentialImpactText><gtr:fund><gtr:end>2018-04-26</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/2512EF1C-401B-4222-9869-A770D4C5FAC7"><gtr:id>2512EF1C-401B-4222-9869-A770D4C5FAC7</gtr:id><gtr:name>BBSRC</gtr:name></gtr:funder><gtr:start>2014-11-28</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>330455</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Intellihep Ltd</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Intellihep</gtr:description><gtr:id>348F6246-FB78-41FC-A5D7-9D7D3E02831E</gtr:id><gtr:impact>Outputs are in progress</gtr:impact><gtr:outcomeId>58c96abdce1768.11136361-1</gtr:outcomeId><gtr:partnerContribution>Provision of chemically modified heparin libraries for structural charachterisation</gtr:partnerContribution><gtr:piContribution>Use of modified heparin libraries and the sequence determination thereof.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Liverpool John Moores University</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Liverpool John Moores University - Dr Powell</gtr:description><gtr:id>ECA40743-0CE3-4407-A45B-215541BF9D4F</gtr:id><gtr:impact>None to date (papers in preparation).</gtr:impact><gtr:outcomeId>56e09ac5622244.88514138-1</gtr:outcomeId><gtr:partnerContribution>Independent method validation.</gtr:partnerContribution><gtr:piContribution>Knowledge transfer for new methodology.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>MI Engineering Ltd</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>MI Engineering Ltd</gtr:description><gtr:id>76F4742B-7476-469E-966C-DDE00477D3A6</gtr:id><gtr:impact>Multidisciplinary collaboration - Engineering, Biophysics, Optics and Electronics. Knowledge transferred from the industrial collaborator to the academic partner has led to research output in the form of one publication to-date (Curtis, A. et al. Heat dissipation of hybrid iron oxide-gold nanoparticles in an agar phantom. (2015) Journal of Nanomedicine &amp;amp; Nanotechnology. DOI 10.4172/2157-7439.1000335).</gtr:impact><gtr:outcomeId>56e09673130e04.77400641-1</gtr:outcomeId><gtr:partnerContribution>Donation of prototype next-generation LIF based detector. Use of manufacturing facilities &amp;amp; associates staff.</gtr:partnerContribution><gtr:piContribution>Ongoing benchmarking &amp;amp; development of next-generation LIF based detector.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Liverpool</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Institute of Integrative Biology</gtr:department><gtr:description>University of Liverpool - Yates</gtr:description><gtr:id>396ACA9A-6036-405C-86C9-594C58C14CE1</gtr:id><gtr:impact>Publication of 2 research papers.

Multi-disciplinary:
Carbohydrate chemistry
Biophysical analysis
Glycobiology</gtr:impact><gtr:outcomeId>56e0513b298c15.81695982-1</gtr:outcomeId><gtr:partnerContribution>Fully characterized modified GAG compounds</gtr:partnerContribution><gtr:piContribution>Knowledge transfer of state-of-the-art GAG detection methodologies</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Workshop at UNESP Institute of Biotechnology (IBTEC), Botucatu, Brazil</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>55C38C1E-7494-431C-A878-746465226FA3</gtr:id><gtr:impact>Workshop on International Scientific Cooperation between UNESP Institute of Biotechnology (IBTEC), Botucatu, Brazil and Keele University. New collaborations are in initial stages.</gtr:impact><gtr:outcomeId>56e09c59c34ff0.40627664</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Industry/Business</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>UNIFESP</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>BEAB1781-1CEC-40D1-AB98-2A431113BC5A</gtr:id><gtr:impact>Research presentation at UNIFESP - Universidade Federal de S&amp;atilde;o Paulo. Audience included academics, post-graduates, under-graduates, clinicians and policy makers.</gtr:impact><gtr:outcomeId>58ca665ba7f0a2.12157376</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>2600</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Seed Funding</gtr:description><gtr:end>2016-06-02</gtr:end><gtr:fundingOrg>Keele University</gtr:fundingOrg><gtr:id>84672AAC-5B20-4D18-9786-AAAACA2283F6</gtr:id><gtr:outcomeId>56e097e8d37980.40344654</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-05-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:keyFindingsOutput><gtr:description>1) The limits of detection for Bodipy labelled GAG derived disaccharides has been established for conventional (Xe lamp-based) fluorescence and Laser Induced Fluorescence (LIF) using High Performance Anion Exchange Chromatography (HP-AEC).

2) Novel methodology has been developed to port the Bodipy (fluorescent-based) GAG disaccharide analysis into a reverse-phase format for HPLC. RP-HPLC is more commonplace in research laboratories, cheaper and does not require corrosive solvents in contrast to HP-AEC. 

3) Methodology for the aqueous Bodipy labeling of GAG-derived oligosaccharides has been established for the first time.</gtr:description><gtr:exploitationPathways>1) The use of Laser Induced Fluorescence for GAG disaccharide analysis will facilitate structure-function studies on sub-femtomolar concentrations of GAG; previously not possible using conventional, bulb based detectors. This technological advance opens up the possibility of GAG analysis on extremely scarce samples, e.g. those obtained via microdisection. 

2) The development of a reverse-phase HPLC method for Bodipy-GAG disaccharide analysis will enhance significantly the availability and future use of this analysis technique. The current technique (HP-AEX) requires specialist equipment, whereas RP-HPLC instrumentation is widely utilised in most research laboratory environments. 

3) Fluorescent labelling in aqueous conditions permits high sensitivity structural analysis of GAG-derived oligosaccharides previously not possible with the Bodipy fluorophore. This was due to solubility issues with conventional strategies and the solvent of choice, DMSO.</gtr:exploitationPathways><gtr:id>D67D3597-5282-449E-8A3B-E4709842C645</gtr:id><gtr:outcomeId>56e08db90e60a0.30267592</gtr:outcomeId><gtr:sectors><gtr:sector>Agriculture, Food and Drink,Healthcare,Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:sectors></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs><gtr:productOutput><gtr:description>Library of semi-synthetic GAG analogues for selective intervention in GAG modulated/regulated disease states.</gtr:description><gtr:id>2B6795D2-49E9-4E52-9D43-6236484736F2</gtr:id><gtr:impact>Library of GAG analogues as been outsourced to relevant research groups and preliminary data of efficacy obtained for Zika, HIV and Influenza viruses, parasitic infections and BACE inhibition in Alzheimer;s disease.</gtr:impact><gtr:outcomeId>58ca686ec27884.84653185</gtr:outcomeId><gtr:stage>Initial development</gtr:stage><gtr:status>Under active development/distribution</gtr:status><gtr:title>GAG analogues</gtr:title><gtr:type>Therapeutic Intervention - Drug</gtr:type><gtr:yearDevCompleted>2017</gtr:yearDevCompleted></gtr:productOutput></gtr:productOutputs><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Reverse phase fluorescent (Bodipy labelled) disaccharide analysis of GAGs.</gtr:description><gtr:id>3333C92F-2783-4F25-8218-E95A1B101F7D</gtr:id><gtr:impact>Development of a new collaboration with Dr Andrew Powell (Liverpool John Moores University) to exploit new methodologies.</gtr:impact><gtr:outcomeId>56e098df67bfe8.83994284</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Bodipy RP-HPLC</gtr:title><gtr:type>Biological samples</gtr:type><gtr:yearFirstProvided>2016</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Methodology has been developed to allow for the first time the Bodipy labelling of GAG derived oligosaccharides prior to subsequent structural analysis. Previously, only small saccharides could be labelled owing to the significant charge of the molecules and their limited solubility in DMSO.</gtr:description><gtr:id>F91C6652-3BB2-40AD-B092-B05AEC95B420</gtr:id><gtr:impact>Further cemented collaborative links with the University of Liverpool and Intellihep Limited to utilise this methodology.</gtr:impact><gtr:outcomeId>58ca6771e25be9.16664764</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Aqueous Bodipy labelling of oligosaccharides for structural analysis</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2017</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>D3E1081B-A8C8-4A74-A6BF-2A0516D99896</gtr:id><gtr:title>A semi-synthetic glycosaminoglycan analogue inhibits and reverses Plasmodium falciparum cytoadherence.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/525f0aa9b75a329ba02b752c076c7854"><gtr:id>525f0aa9b75a329ba02b752c076c7854</gtr:id><gtr:otherNames>Skidmore MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>5aa96fe3b29187.93470584</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>595E85A5-B8ED-42F5-8C3F-2AF517DC9E29</gtr:id><gtr:title>Heat Dissipation of Hybrid Iron Oxide-Gold Nanoparticles in an Agar Phantom</gtr:title><gtr:parentPublicationTitle>Journal of Nanomedicine &amp; Nanotechnology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1c23a304d8ab0a4a89b34cee116d0983"><gtr:id>1c23a304d8ab0a4a89b34cee116d0983</gtr:id><gtr:otherNames>Curtis A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:outcomeId>56ab13fb827bb4.89948350</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>28D8E286-EA09-4274-BDB3-7E9F38C63E71</gtr:id><gtr:title>Heparin derivatives for the targeting of multiple activities in the inflammatory response.</gtr:title><gtr:parentPublicationTitle>Carbohydrate polymers</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bcbb42232d9c8fbb5bab2b649d52e6dd"><gtr:id>bcbb42232d9c8fbb5bab2b649d52e6dd</gtr:id><gtr:otherNames>Veraldi N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0144-8617</gtr:issn><gtr:outcomeId>56ab12e5d96471.94615277</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>425CBCB2-D07D-47A9-8142-DE8E6B07FFE4</gtr:id><gtr:title>Inhibition of influenza H5N1 invasion by modified heparin derivatives</gtr:title><gtr:parentPublicationTitle>MedChemComm</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/35e3409b071e279a8053a50dee0790ce"><gtr:id>35e3409b071e279a8053a50dee0790ce</gtr:id><gtr:otherNames>Skidmore M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:outcomeId>56ab1278a12573.83998411</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>442F0C57-473B-4475-BDEC-74DFC88F1318</gtr:id><gtr:title>Heparin prevents Zika virus induced-cytopathic effects in human neural progenitor cells.</gtr:title><gtr:parentPublicationTitle>Antiviral research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7b6d2c818549d77cec25e32cb6bbe0a4"><gtr:id>7b6d2c818549d77cec25e32cb6bbe0a4</gtr:id><gtr:otherNames>Ghezzi S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0166-3542</gtr:issn><gtr:outcomeId>58c968ebbc9be7.86679741</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>38E03F92-4C2A-4A39-BF51-8A9C928F39BA</gtr:id><gtr:title>In vitro investigations on the effects of semi-synthetic, sulphated carbohydrates on the immune status of cultured common carp (Cyprinus carpio) leucocytes.</gtr:title><gtr:parentPublicationTitle>Fish &amp; shellfish immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5b7b5d13317614ed49544dcd012febe0"><gtr:id>5b7b5d13317614ed49544dcd012febe0</gtr:id><gtr:otherNames>Kareem N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>1050-4648</gtr:issn><gtr:outcomeId>5aa971d99968e5.51336683</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A6CA88D0-87DC-4330-B2C8-352842DFF4DF</gtr:id><gtr:title>Identification of Heparin Modifications and Polysaccharide Inhibitors of Plasmodium falciparum Merozoite Invasion That Have Potential for Novel Drug Development.</gtr:title><gtr:parentPublicationTitle>Antimicrobial agents and chemotherapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/094dc250b162ab5f7ad66b1440ea75f9"><gtr:id>094dc250b162ab5f7ad66b1440ea75f9</gtr:id><gtr:otherNames>Boyle MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0066-4804</gtr:issn><gtr:outcomeId>5aa970c6e6a2b4.38511881</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D1FD8D9F-DE7E-4483-8DF1-5BF8196CF508</gtr:id><gtr:title>F labelled glycosaminoglycan probes for solution NMR and non-linear (CARS) microscopy.</gtr:title><gtr:parentPublicationTitle>Glycoconjugate journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/20a94c2f0b8b4c942b9923d7823f693c"><gtr:id>20a94c2f0b8b4c942b9923d7823f693c</gtr:id><gtr:otherNames>Lima MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0282-0080</gtr:issn><gtr:outcomeId>58c9692de5ed73.41915059</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">BB/L023717/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects><gtr:researchSubject><gtr:id>9BDF80E2-029E-4505-B7EE-DB0FA633E483</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Omic sciences &amp; technologies</gtr:text></gtr:researchSubject><gtr:researchSubject><gtr:id>9CD2DA3B-F052-4076-95ED-10F46E76C382</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Optics, photonics &amp; lasers</gtr:text></gtr:researchSubject><gtr:researchSubject><gtr:id>FB535BD0-E265-4C0A-8532-32DCB83A3951</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Tools, technologies &amp; methods</gtr:text></gtr:researchSubject></gtr:researchSubjects><gtr:researchTopics><gtr:researchTopic><gtr:id>355E4436-33EB-43B6-9E90-102E2E2280BC</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Glycomics</gtr:text></gtr:researchTopic><gtr:researchTopic><gtr:id>3730AA1C-F09A-4945-8874-DEF6237C50CD</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Lasers &amp; Optics</gtr:text></gtr:researchTopic><gtr:researchTopic><gtr:id>80A9D6C5-792D-4DD9-9138-BEC1BB556AA9</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Technology and method dev</gtr:text></gtr:researchTopic><gtr:researchTopic><gtr:id>3493671D-A4CF-4197-90A7-3CCFBE1C0627</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Tools for the biosciences</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>